Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,844 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatitis C virus replication in chronic liver disease.
Margin S, Craxì A, Fabiano C, Fiorentino G, Almasio P, Di Marco V, Lo Iacono O, Bruno R, Pinzello GB, Palazzo U, et al. Margin S, et al. Among authors: bruno r. J Hepatol. 1991;13 Suppl 4:S40-1. doi: 10.1016/0168-8278(91)90021-3. J Hepatol. 1991. PMID: 1668331 No abstract available.
Alpha-interferon and post-transfusion NANB hepatitis.
Craxì A, Di Marco V, Volpes R, Bruno R, Palazzo U, Maggio A. Craxì A, et al. Among authors: bruno r. Lancet. 1989 Feb 18;1(8634):391-2. doi: 10.1016/s0140-6736(89)91774-1. Lancet. 1989. PMID: 2563552 Clinical Trial. No abstract available.
Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis.
Di Marco V, Covolo L, Calvaruso V, Levrero M, Puoti M, Suter F, Gaeta GB, Ferrari C, Raimondo G, Fattovich G, Santantonio T, Alberti A, Bruno R, Mussini C, Mondelli M, Donato F, Craxì A; Multicenter Italian Group for the Study of Hepatitis C. Di Marco V, et al. Among authors: bruno r. J Viral Hepat. 2013 Nov;20(11):790-800. doi: 10.1111/jvh.12106. Epub 2013 Sep 15. J Viral Hepat. 2013. PMID: 24168258
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV.
Karampatou A, Han X, Kondili LA, Taliani G, Ciancio A, Morisco F, Critelli RM, Baraldi E, Bernabucci V, Troshina G, Guarino M, Tagliavini S, D'Ambrosio F, Bristot L, Turco L, Rosato S, Vella S, Trenti T, Neri I, La Marca A, Manthena S, Goldstein AS, Bruno S, Bao Y, Gonzalez YS, Villa E; PITER framework investigators; PITER Investigators. Karampatou A, et al. J Hepatol. 2017 Sep 5:S0168-8278(17)32259-6. doi: 10.1016/j.jhep.2017.08.019. Online ahead of print. J Hepatol. 2017. PMID: 28882581 Free article.
Prioritization of high-cost new drugs for HCV: making sustainability ethical.
Craxì L, Sacchini D, Refolo P, Minacori R, Daloiso V, Ricci G, Bruno R, Cammà C, Cicchetti A, Gasbarrini A, Spagnolo AG. Craxì L, et al. Among authors: bruno r. Eur Rev Med Pharmacol Sci. 2016;20(6):1044-51. Eur Rev Med Pharmacol Sci. 2016. PMID: 27049255 Free article. Review.
Prophylaxis and treatment of hepatitis B in immunocompromised patients.
Marzano A, Angelucci E, Andreone P, Brunetto M, Bruno R, Burra P, Caraceni P, Daniele B, Di Marco V, Fabrizi F, Fagiuoli S, Grossi P, Lampertico P, Meliconi R, Mangia A, Puoti M, Raimondo G, Smedile A; Italian Association for the Study of the Liver. Marzano A, et al. Among authors: bruno r. Dig Liver Dis. 2007 May;39(5):397-408. doi: 10.1016/j.dld.2006.12.017. Epub 2007 Mar 26. Dig Liver Dis. 2007. PMID: 17382608 Review.
Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C.
Gaeta GB, Precone DF, Felaco FM, Bruno R, Spadaro A, Stornaiuolo G, Stanzione M, Ascione T, De Sena R, Campanone A, Filice G, Piccinino F. Gaeta GB, et al. Among authors: bruno r. Aliment Pharmacol Ther. 2002 Sep;16(9):1633-9. doi: 10.1046/j.1365-2036.2002.01331.x. Aliment Pharmacol Ther. 2002. PMID: 12197842 Free article.
1,844 results